Amitiza Reduces Symptoms In 26% Of Ibs-D Patients.

Like most IBS drugs, the efficacy rate is low, and 49% of patients report at least one side effect.

Amitiza reduces symptoms in 26% of IBS-D patients.

Like most IBS drugs, the efficacy rate is low, and 49% of patients report at least one side effect.

 
⚠ We use Cookies on our website to enhance your browsing experience. You can read how we use Cookies on our Privacy Policy.
Headache © 2019 All Rights Reserved.
NOTE: All contents on this website has been created with the permission of content owners from Youtube, Facebook, Pinterest and other sites..